ホーム › 卵巣がん › ウィスコンシン › Madison
Madison、WIにおける卵巣がんの臨床試験
Madisonとその周辺地域（約30マイル以内）の拠点で、卵巣がんに関する13件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
被験者募集中第2/3相
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
被験者募集中第2相
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
被験者募集中第1/2相
- University of Wisconsin Carbone Cancer Center, Madison
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
被験者募集中第2相
- UW Health Carbone Cancer Center, Madison
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
被験者募集中第2相
- Research Site, Madison
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
被験者募集中第3相
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
被験者募集中第1相
- University of Wisconsin - Carbone Cancer Center, Madison
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
被験者募集中第2相
- University of Wisconsin, Madison
Cognitive Impact of Neoadjuvant Chemotherapy for Gynecologic Cancers
被験者募集中観察研究
- UW Carbone Cancer Center, Madison
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
被験者募集中
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
被験者募集中第2相
- University of Wisconsin - Carbone Cancer Center - University Hospital, Madison
Lead-212 PSV359 Therapy for Patients With Solid Tumors
被験者募集中第1/2相
- University of Wisconsin, Madison
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
被験者募集中第1相
- University of Wisconsin Carbone Cancer Center, Madison
他の都市における卵巣がんの試験
- Houston, TX89件の研究
- New York City, NY69件の研究
- Boston, MA61件の研究
- Los Angeles, CA50件の研究
- Nashville, TN49件の研究
- Arlington, VA46件の研究
- Philadelphia, PA44件の研究
- Columbus, OH39件の研究
- St. Louis, MO38件の研究
- Chicago, IL36件の研究
- San Antonio, TX31件の研究
- Cleveland, OH30件の研究
Madisonにおける他の研究
- 前立腺がん29件の研究
- 大腸癌23件の研究
- 乳がん22件の研究
- 転移性癌21件の研究
- 急性骨髄性白血病16件の研究
- 非小細胞肺癌16件の研究
- 悪性黒色腫15件の研究
- がん（全種類）14件の研究
- 胃癌11件の研究
- 膵臓がん10件の研究
- 肺がん10件の研究
- 多発性骨髄腫9件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。